KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Endava (DAVA) EBITDA (2017 - 2025)

Endava's EBITDA history spans 9 years, with the latest figure at -$3.9 million for Q4 2025.

  • Quarterly EBITDA fell 282.99% to -$3.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.5 million through Dec 2025, up 226.51% year-over-year, with the annual reading at $42.0 million for FY2025, 65.34% up from the prior year.
  • EBITDA came in at -$3.9 million for Q4 2025, roughly flat from -$3.9 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $38.5 million in Q4 2022 to a low of -$3.9 million in Q4 2025.
  • The 5-year median for EBITDA is $22.8 million (2021), against an average of $18.6 million.
  • The largest YoY upside for EBITDA was 991.76% in 2025 against a maximum downside of 282.99% in 2025.
  • Endava's EBITDA stood at $26.2 million in 2021, then soared by 46.86% to $38.5 million in 2022, then tumbled by 85.1% to $5.7 million in 2023, then plummeted by 62.54% to $2.1 million in 2024, then plummeted by 282.99% to -$3.9 million in 2025.
  • Per Business Quant, the three most recent readings for DAVA's EBITDA are -$3.9 million (Q4 2025), -$3.9 million (Q3 2025), and $11.6 million (Q2 2025).